Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × ABTL0812 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

pembrolizumab 533 Carboplatin 340 Paclitaxel 252 Cisplatin 245 Gemcitabine 218 Nivolumab 178 Pemetrexed 174 Docetaxel 171 Bevacizumab 168 Injections 142 Cyclophosphamide 130 atezolizumab 128 Capecitabine 118 Dexamethasone 115 Oxaliplatin 114 Fluorouracil 112 durvalumab 103 Fulvestrant 96 130-nm albumin-bound paclitaxel 96 Rituximab 89 fludarabine 87 venetoclax 85 Cetuximab 83 Leucovorin 82 Lenalidomide 81 Prednisone 79 Azacitidine 74 enzalutamide 71 tislelizumab 69 Trastuzumab 66

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03417921 2025-10-01

Pancreatic

Ability Pharmaceuticals SL

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡